Miach Orthopaedics, Inc. announced that it will issue 20,810,308 series B-1 preferred shares at a price of $0.975167 per share for gross proceeds of $20,293,525.621436, and 12,162,390 series B-2 preferred shares at a price of $0.828891 per share for gross proceeds of $10,081,295.60949, for aggregate gross proceeds of $30,374,821.230926 on January 20, 2023. The shares are issued at a par value of $0.001 per share. The shares are non-redeemable.

The series B-1 shares, and series B-2 shares will be convertible into common shares at a fixed conversion price of $0.975167, and $0.828891 per share respectively. The round will be raised at a post-money valuation of $70,451,267.